-
SML3691-25MG
ANAGRELIDE ANALOG A6 (C005B-480767)
Price: $1,001.04List Price: $1,112.27ANAGRELIDE ANALOG A6 -
SML3691-5MG
ANAGRELIDE ANALOG A6 (C005B-480768)
Price: $312.13List Price: $346.81ANAGRELIDE ANALOG A6 -
1034750-25MG
ANAGRELIDE RELATED COMPOUND B UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,607.39List Price: $2,897.10This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
1034771-25MG
ANAGRELIDE RELATED COMPOUND C UNITED STATES PHARMACOPEIA (USP) REFERENCE STANDARD
Price: $2,679.32List Price: $2,977.02This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the -
189511-10MG
AUTOTAXIN INHIBITOR II HA13 1PC X 10MG
Price: $324.13List Price: $360.14A thiazolidinedione that is designed to target the ATX active site thr210 with a boronic moiety and shown to potently inhibit ATX lysoPLD activity (IC 50 ~28 nM using recombinant human ATX or human plasma) in a reversible manner with a mixed-type -
A5327-10 mg
PDE3 inhibitor used to treat essential thrombocytosis and other chronic myeloproliferative disorders. It suppresses megakaryocytopoiesis and inhibits thombopoietin-mediated cell differentiation. (C003B-255212)
Price: $309.38List Price: $343.76Anagrelide is an imidazoquinazoline anti-platelet compound that inhibits platelet aggregation at high doses and decreases platelet activity at low doses. Anagrelide inhibits phosphodiesterase III (PDE3). -
A5327-100 mg
PDE3 inhibitor used to treat essential thrombocytosis and other chronic myeloproliferative disorders. It suppresses megakaryocytopoiesis and inhibits thombopoietin-mediated cell differentiation. (C003B-256004)
Price: $1,086.98List Price: $1,207.76Anagrelide is an imidazoquinazoline anti-platelet compound that inhibits platelet aggregation at high doses and decreases platelet activity at low doses. Anagrelide inhibits phosphodiesterase III (PDE3). -
A5327-25 mg
PDE3 inhibitor used to treat essential thrombocytosis and other chronic myeloproliferative disorders. It suppresses megakaryocytopoiesis and inhibits thombopoietin-mediated cell differentiation. (C003B-256079)
Price: $565.63List Price: $628.48Anagrelide is an imidazoquinazoline anti-platelet compound that inhibits platelet aggregation at high doses and decreases platelet activity at low doses. Anagrelide inhibits phosphodiesterase III (PDE3).